X
SANA icon

Xponance’s Sana Biotechnology SANA Stock Holding History

Xponance’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.5K Buy
17,631
+2,551
+17% +$8.22K ﹤0.01% 1771
2026
Q1 		$43.4K Buy
15,080
+2,012
+15% +$7.92K ﹤0.01% 1641
2025
Q4 		$53.2K Buy
13,068
+2,662
+26% +$11.9K ﹤0.01% 1521
2025
Q3 		$36.9K Buy
10,406
+93
+0.9% +$336 ﹤0.01% 1502
2025
Q2 		$28.2K Buy
+10,313
New +$21.3K ﹤0.01% 1485

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Xponance's SANA Position: Q2 2026 in Review

Xponance increased its Sana Biotechnology (SANA) stake by 17% in Q2 2026, buying an estimated $8.22K and bringing the position to 17,631 shares worth $61.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

Xponance first reported a position in SANA in Q2 2025 and has held it in 5 quarters since. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Xponance held 17,631 shares of Sana Biotechnology worth $61.5K as of Q2 2026.
  • Xponance bought 2,551 Sana Biotechnology shares in Q2 2026, an estimated $8.22K.
  • Sana Biotechnology made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1771 holding.
  • Xponance first reported a position in Sana Biotechnology in Q2 2025 and has held it in 5 quarters since.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.